May 19 2022

Classification of the active ingredient bismuth subsalicylate


Risk level in pregnancy: This medicine is classified as Category category C for the first quarter and D during the last two quarters.

Update 18.07.2009

Meaning of category C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.